chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Two weeks ago my daughter had the updated Tdap as school required even though she had it ten years ago as small child. She was out of school two days last week with flu like symptoms and three days this week with nausea that wont subside, and very sleepy. All I have given her so far is Equate over the counter anti-nausea liquid, seems to help only little. My daughter has allergies to small bug bites and is on Loratadine for them. I related this to a flu nausea that my Aunt had last week and was hospitalized for it, only being dehydrated as she is an alcoholic, so I thought this was what my daughter had as she gets every flu that the school has going around at any given time, yet she doesnt have that severe of nausea. Doctor took blood sample last week, I havent heard back yet. I contacted CDC with this info also, being a concerned parent.
Left upper arm became red, hard, swollen to twice normal size for over a week, by the end of the week I started having electrical zapping feelings in my body. Then I couldn?t sleep for two days and nights even after taking sleeping pills. Then my body started twitching uncontrollably. I went to the nearest ER and was there for 5 hours. They ultimately told me I had extremely high blood pressure in the dangerous level and was either going to have a stroke or heart attack if they couldn?t get it lowered. I NEVER had high blood pressure previously at any body twitching or convulsing. I was very afraid at that time as they were preparing to life flight me to facility to be hospitalized there. They were able to lower my blood pressure down after giving me two types of meds and I was sent home. I followed up with my primary care physician two days later. I?m now on blood pressure meds for the rest of my life. She advised me to NOT take the second vaccination. Which I am following. I also did have a positive case of COVID 19 in December of 2020 which I easily recovered from after 2 weeks.
Red swollen area on (L) thigh around injection site approx. 4 cm x 2 cm. Mild tenderness with palpation.
Teeth chattering shivers; Extreme fatigue; Body aches; Fever; This is a spontaneous report from a contactable nurse, the patient. A 56-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 10:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and COVID-19. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 10:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 20:15, the patient experienced teeth chattering shivers, extreme fatigue, body aches and fever. The events did not result in doctor or other health care professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events teeth chattering shivers, extreme fatigue, body aches and fever were not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
106 F fever on evening /p 1st DTP immun. Low grade fever for 3-4 more days.
My late husband would be sick for 2 weeks after getting flu shots; Initial information was received on 03-Dec-2002 regarding an unsolicited valid non-serious case from a consumer or non-health care professional (patient's wife) via social media.  This case involves a male patient (age unspecified) who experienced sickness for 2 weeks, after vaccination with INFLUENZA VACCINE [flu shots].  Medical history, medical treatment, vaccination, family history and concomitant medication were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient had a non-serious sickness (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  on an unknown date, the patient was recovered from illness (sickness for 2 weeks).  The patient was already died at the time of reporting, the cause of death was not reported.
Death; A spontaneous report was received from a consumer concerning a 66-year-old, female patient, who received Moderna's covid-19 vaccine (mRNA-1273) and died.   The patient's medical history included covid-19 infection on 04 Nov 2020. No relevant concomitant medications were mentioned.   On 28 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number:unknown) intramuscularly for prophylaxis of COVID-19 infection.   On 09 Mar 2021, the patient died.  CT was done and did not find any atherosclerosis but found her lungs were whited out,heavily filled with fluid which he described could've been pulmonary edema. She had tested Covid positive back on 04 Nov 2020.    Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.  The outcome of the event was fatal.  The patient died on 09 Mar 2021 and the cause of death was unknown. An autopsy was planned on 11 Mar 2021.; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.; Reported Cause(s) of Death: Unknown cause of death
shingles on her eye and forehead, it has persisted and is painful; This is a spontaneous report from a contactable consumer (patient). A 85-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL0140, Expiration Date: 31Mar2021) via an unspecified route of administration, administered in right arm on 13Jan2021 11:10 am at 0.3 ml (SINGLE DOSE) for covid-19 immunisation. Medical history included shingles (Family history) as sister had shingles 10 years ago, grandson on back a couple years ago. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was provided as N/A. Additional Administered Vaccines was administered on same date with the vaccine considered as suspect was none. Vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was none. AE(s) following prior vaccinations was none. There were no concomitant medications. The patient experienced shingles on her eye and forehead, it has persisted and is painful (herpes zoster) (non-serious) on 21Jan2021. Caller mentioned that she received the 1st shot on 13Jan2021 and developed Shingles 10 days after (date mentioned was 21Jan2021). She is scheduled to take the 2nd dose on 03Feb2021 and is asking if she should hold off for a week or so for her 2nd shot because of the shingles being still there. If so, she is also asking whether she should she restart the vaccine if she goes over the 21 days. Caller is a consumer, states she had her first Covid vaccine on 13Jan2021, states ten days later developed shingles on her eye and forehead. States she is supposed to take second shot on 03Feb2021, next Wednesday, caller states she is concerned if she does not take it, wants to know if can she put it off for a week or two and if she needs to will she have to restart with the first dose again. Caller asks if there is any kind of special diet along with the shingles that we know of. Caller states she actually developed the shingles on 21Jan2021, states it has persisted and is painful, states she is treating the shingles with an antiviral medication. Caller states the ophthalmologist says she has no blisters on eye or anything. Vaccination Facility Type included Other. Vaccine was not Administered at Facility. The outcome of event was not recovered.
On 7/18/05, child received DTAP/IPV at 10:00. That afernoon, child began to vomit profusely. Was seen at ER and received IV fluids. After rehydration at ER, child was able to tolerate Pedialyte. Child discharged to home. Seen as follow-up by this office on 7/19/05. Child appeared normal. DX: Probable reaction to DTAP. ? episode ? convulsive activity in car on the way home. 6 pages attached to this form-hospital discharge summary. Decreased appetite, dehydrated, 2 small raised erythematous lesions on the cheeks, excoriated, each several mm in diameter consistent with insect bites. Given Zofran 1mg IV. Call your doctor this morning to set up appointment for recheck this afternoon.
It was reported that a 17 year old male received 3 vaccinations on 4/17/2000. Reportedly 24 hours after the vax, the pt developed soreness in both legs. It was reported that the pt was admitted to the hospital and the diagnosis eliminated any relationship to the vaccines given. Exact diagnosis unspecified. Additional information is being requested. Follow up information received 05/25/2001 reported the patient recovered form this experience. Was found not to be a reaction to vaccines. No further information available regarding this patient or this case.
malaise; weaker than usual; lymph node swollen in abdomen; hematuria; aches; chills; fever; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HAEMATURIA (hematuria), MALAISE (malaise), PAIN (aches), CHILLS (chills) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced HAEMATURIA (hematuria), PAIN (aches), CHILLS (chills) and PYREXIA (fever). On 07-Mar-2021, the patient experienced LYMPHADENOPATHY (lymph node swollen in abdomen). On 08-Mar-2021, the patient experienced MALAISE (malaise) and FATIGUE (weaker than usual). On 07-Mar-2021, HAEMATURIA (hematuria), PAIN (aches), CHILLS (chills) and PYREXIA (fever) had resolved. At the time of the report, MALAISE (malaise), FATIGUE (weaker than usual) and LYMPHADENOPATHY (lymph node swollen in abdomen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Blood test normal: normal (normal) normal. On 06-Mar-2021, Computerised tomogram: abnormal (abnormal) lymph node swollen in abdomen.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021 at 1:13 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 12:27 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 60.85 for dose administered on 27-Feb-2021 and 60.93 for dose administered on 27-Mar-2021. No concomitant medications were reported. Batch number 014M20A administered on 27-Feb-2021 underwent temperature excursion with temperature range of 35 degrees Fahrenheit from 01:00 PM to 02:00 PM. This vial was moved to fridge on 24-Feb-2021 and beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 27-Feb-2021. Batch number 019B21A administered on 27-Mar-2021 underwent temperature excursion with temperature range of 35 degrees Fahrenheit from 09:00 AM to 10:00 AM. This vial was moved to fridge on 23-Mar-2021 and beyond use date for the vial was reported as 22-Apr-2021. Product moved to clinic on 27-Mar-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. No treatment medications were reported.
pt rec vax & devel an allergic rxn characterized by diff breathing, wheezing & swelling of the eyes & face;taken to ER;tx w/steroids, proventil, DPH & recovered;
Began with headache, body aches, and feeling tired. Progressed to hives on stomach - called ER recommended I take Benedryl, I did.  Hives progressed and worsened, I passed out and my husband had to call 911.  I was taken by ambulance to the ER and admitted to the hospital.  I stayed until on Monday 5/24/2021.  I was released 1:30pm. Wednesday 5/27/2021 I felt jittery I called my PCP they could not get me in and recommended I go to the walk in clinc, I did and they reduced some of the medications I was put on from the hospital. I have a follow up appointment with my PCP 6/2/2021.
FEVER; LIGHT HEADACHE; This spontaneous report received from a parent concerned a 25 year old female. The patient's weight was 50 kilograms, and height was 170 centimeters. The patient's concurrent conditions included: anorexia, and other pre-existing medical conditions included: Patient was not pregnant and no breast feeding at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286 expiry: UNKNOWN) dose was not reported, administered on 18-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On AUG-2021, the patient experienced fever. On AUG-2021, the patient experienced light headache. Laboratory data included: Body temperature (NR: not provided) 100.4 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and the outcome of light headache was not reported. This report was non-serious.
Next am Parent noticed redness, swelling and warmth of entire upper Left arm with some redness under same arm area. Child complained of some itching at area but did not seem to have pain per Parent. Child was taken to his PCP. No treatment given or recommended per Parent. States Dr. examined child and told Parent that child might have had a reaction to a "preservative" in the vaccine. Parent states symptoms have gradually  improved over the course of the week. Parent denied any anaphylactic type symptoms at any time after vaccines given.
Evening 5/14 - Chills, headache, nausea 5/15 - Body aches
Pain, swelling, lump in her groin.  seen at pcp clinic 12/2/10 am for immunization reaction as flu and Pneumovax was given at same site.  Tx of lortab 5 1-2 tabs q6hrs. otc Benadryl 1 pill tid and Zyrtec 1 pill a day.  Will follow up if not improved.
Sudden lapse of stiff joints at night. Tendonitis in hands right after waking up each morning. I am healthy and active and never experienced this before until right after being vacinated.
Fever developed and persisted. Patient admitted on 08/30/13 and spinal tap showed 600 WBCs and 100RBCs with elevated protein. Blood and spinal bacterial cultures were neg but awaiting viral culture result for herpes.
Information has been received from a medical assistant referring to a 7 month old patient of unknown gender. The patient's concurrent condition, concomitant therapy and medical history were unknown.     On 28-NOV-2017, the patient was vaccinated with a first dose of VAQTA (lot # N019924, expiration date: 02-SEP-2018, intramuscular, dose and frequency were unknown) for prophylaxis at 7 months of age(Inappropriate age at vaccine administration). No adverse effects were reported.
A few days after I received vaccination a lymph node in my under arm became swollen and sore.
24 hours after vaccine developed sore right arm, soreness in right upper chest and itching at the injection site.  30-36 hours later increased soreness, itching and tingling in right arm as well as 2 red spots on the right arm.
patient died after getting the shot from what it was to prevent; Initial information received on 03-Dec-2020 regarding an unsolicited valid serious social media case received from a consumer or non-healthcare professional.  This case involves a male patient (age not reported) who died after getting the INFLUENZA VACCINE from what it was to prevent (influenza).  The patient's medical history, past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer batch number and expiry date not reported via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient died (unknown latency) following the administration of INFLUENZA VACCINE from what it was to prevent (influenza).   No laboratories details reported.  It was not reported if the patient received any corrective treatment before he died.  It was unknown if an autopsy was done.   Information on the batch number was requested.; Sender's Comments: This poorly documented social media case concerns a male patient who had influenza infection and died after vaccination with INFLUENZA VACCINE (unknown manufacturer). Also, patient's medical condition at the time of vaccination, autopsy result and lab tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the suspect vaccine cannot be assessed.; Reported Cause(s) of Death: patient died after getting the shot from what it was to prevent
big rash; chills; running nose; sneezing; bad dry cough; This is a spontaneous report from a contactable other healthcare professional (patient). A 76-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number: EN6200, expiration date was not reported) via an unspecified route of administration, in left arm, on 24Feb2021 13:00 (at the age of 76-years-old), at dose 1, single for covid-19 immunization. Medical history included known allergies. The patient used other medications in two weeks (unspecified). Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine. The patient has not been tested with covid-19 after the vaccination. The patient experienced bad dry cough on 28Feb2021 17:00, running nose and sneezing on next day (01Mar2021) and on the third day (02Mar2021), her body became one big rash and she got chills. The outcome of the events was not recovered.    No follow-up attempts are possible. No further information is expected.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult female patient who received Influenza vaccine Quadrivalent. Previously administered products included Flu vaccine with an associated reaction of injection site pain (patient had gotten the flu vaccine every year for the past nine years). On an unknown date, the patient received Influenza vaccine Quadrivalent 2015-2016 season. On an unknown date, less than a year after receiving Influenza vaccine Quadrivalent 2015-2016 season, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to Influenza vaccine Quadrivalent 2015-2016 season. Additional details were provided as follows: The age at the vaccination was not reported. The patient reported that she has gotten the flu vaccine every year for the past nine years and it usually hurts a little at the injection site, but resolved after a couple days. This was fourth of the 9 cases reported by the same reporter for the same patient.
Per phone call from mother, patient passed out in the front yard of their home after receiving vaccines. Nurse advised her on the actions to be taken and if concerns continue to have patient see her PCP.
Approximately 13 hours after vaccination I experienced a fever with chills combined with SEVERE spinal pain as well as right hip pain. and injection site swelling. The hip pain felt like a rod with a huge brushed head on it and felt like it was being continuously twisted into my hip. Vaccine was given on a Saturday.  This pain lasted into Tuesday morning followed by vomiting.  On Tuesday late afternoon my upper and lower lips broke out into numerous painfull blisters that would burst and bleed (I am not a regular to fever or mouth blisters).  It took approximately a week for them to settle down. The fever and chills subside Tuesday evening.  I tried Abreva as well as another professional brand without must success to subside the pain.  Today is day 20 since the outbreak and I still have a little larger than a pea size on the upper lip that is still healing.
severe wrist drop on the right thought to be related to new MRI findings of inflammatory brachial  plexitis Continued weakness in the RUE 6 months after onset of symptoms